Your health matters, mama! And Motherly is here for you with trusted information and resources about pregnancy, postpartum and more.
Some pregnancy symptoms are normal, but others can turn into a sign of something more serious. Send this to all your pregnant friends, stat.
Here’s what to know about the pumping technique—and how to make it work for you.
“This is the first time that we’ve really taken a look at the cost borne by breastfeeding women in dollars and cents terms,” a Yale researcher states.
Too often, women are told to lose weight instead of getting treatment for serious health problems
Alcohol has become a socially acceptable form of self-care—but it's not without risks.
The list of foods to avoid during pregnancy can feel long. Is your dad's perfectly cooked turkey among them?
Here’s what to know about pregnancy-associated breast cancer.
Bobbie For Change x The Breasties is bringing awareness to this glaring insurance gap.
The reintroduction of the Access to Infertility Treatment and Care Act aims to make that happen.
“Can I still breastfeed if I have inverted nipples?”
A 2019 study found that IUDs reduce ovarian cancer risk by 32%—here's what two cancer experts say about the findings.
Menopause is costing both women and employers. The CEO of Elektra Health shares what companies can do about it.
If the agency decides to ban the ingredient, it could mean products for both kids and adults will be pulled from shelves.
Fetal microchimerism means a small number of your baby's cells can travel through the placenta and take root in your body, where they may remain for decades. It can even occur in surrogacy, experts say.
When it comes to building your postpartum care team, it’s hard to know where to start. Here’s a good roster.
Things might start getting weird—but that’s actually perfectly normal.
The survey also found that 1 in 5 women feel ignored or mistreated during prenatal appointments.
We love to see expanded access and innovation in women’s health, but accuracy matters more.
Inaccurate absorbency claims may mask more serious health issues, researchers say.
The first-ever FDA-approved pill for postpartum depression is a landmark achievement, but it could come at a high cost for women in more ways than one.